170 related articles for article (PubMed ID: 17559794)
1. Potency of a tau fibrillization inhibitor is influenced by its aggregation state.
Congdon EE; Necula M; Blackstone RD; Kuret J
Arch Biochem Biophys; 2007 Sep; 465(1):127-35. PubMed ID: 17559794
[TBL] [Abstract][Full Text] [Related]
2. Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases.
Necula M; Chirita CN; Kuret J
Biochemistry; 2005 Aug; 44(30):10227-37. PubMed ID: 16042400
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of tau fibrillization with a multivalent ligand.
Honson NS; Jensen JR; Darby MV; Kuret J
Biochem Biophys Res Commun; 2007 Nov; 363(1):229-34. PubMed ID: 17854770
[TBL] [Abstract][Full Text] [Related]
4. Ligand-dependent inhibition and reversal of tau filament formation.
Chirita C; Necula M; Kuret J
Biochemistry; 2004 Mar; 43(10):2879-87. PubMed ID: 15005623
[TBL] [Abstract][Full Text] [Related]
5. Pseudophosphorylation of tau protein directly modulates its aggregation kinetics.
Chang E; Kim S; Schafer KN; Kuret J
Biochim Biophys Acta; 2011 Feb; 1814(2):388-95. PubMed ID: 20974297
[TBL] [Abstract][Full Text] [Related]
6. Evaluating triggers and enhancers of tau fibrillization.
Kuret J; Congdon EE; Li G; Yin H; Yu X; Zhong Q
Microsc Res Tech; 2005 Jul; 67(3-4):141-55. PubMed ID: 16103995
[TBL] [Abstract][Full Text] [Related]
7. Evidence for an intermediate in tau filament formation.
Chirita CN; Kuret J
Biochemistry; 2004 Feb; 43(6):1704-14. PubMed ID: 14769048
[TBL] [Abstract][Full Text] [Related]
8. Evidence for independent mechanisms and a multiple-hit model of tau assembly.
DeTure M; Granger B; Grover A; Hutton M; Yen SH
Biochem Biophys Res Commun; 2006 Jan; 339(3):858-64. PubMed ID: 16325769
[TBL] [Abstract][Full Text] [Related]
9. Quantitative characterization of heparin binding to Tau protein: implication for inducer-mediated Tau filament formation.
Zhu HL; Fernández C; Fan JB; Shewmaker F; Chen J; Minton AP; Liang Y
J Biol Chem; 2010 Feb; 285(6):3592-3599. PubMed ID: 19959468
[TBL] [Abstract][Full Text] [Related]
10. A light scattering assay for arachidonic acid-induced tau fibrillization without interfering micellization.
Sarthy J; Gamblin TC
Anal Biochem; 2006 Jun; 353(1):150-2. PubMed ID: 16620751
[No Abstract] [Full Text] [Related]
11. Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro.
Necula M; Kuret J
J Biol Chem; 2004 Nov; 279(48):49694-703. PubMed ID: 15364924
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps.
Chang E; Kim S; Yin H; Nagaraja HN; Kuret J
J Neurochem; 2008 Nov; 107(4):1113-23. PubMed ID: 18803694
[TBL] [Abstract][Full Text] [Related]
13. Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants.
Congdon EE; Kim S; Bonchak J; Songrug T; Matzavinos A; Kuret J
J Biol Chem; 2008 May; 283(20):13806-16. PubMed ID: 18359772
[TBL] [Abstract][Full Text] [Related]
14. Tau glycation is involved in aggregation of the protein but not in the formation of filaments.
Ledesma MD; Pérez M; Colaco C; Avila J
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1111-6. PubMed ID: 9846893
[TBL] [Abstract][Full Text] [Related]
15. A static laser light scattering assay for surfactant-induced tau fibrillization.
Necula M; Kuret J
Anal Biochem; 2004 Oct; 333(2):205-15. PubMed ID: 15450794
[TBL] [Abstract][Full Text] [Related]
16. Vitamin B12 Inhibits Tau Fibrillization via Binding to Cysteine Residues of Tau.
Rafiee S; Asadollahi K; Riazi G; Ahmadian S; Saboury AA
ACS Chem Neurosci; 2017 Dec; 8(12):2676-2682. PubMed ID: 28841372
[TBL] [Abstract][Full Text] [Related]
17. Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation.
Rankin CA; Sun Q; Gamblin TC
Brain Res Mol Brain Res; 2005 Jul; 138(1):84-93. PubMed ID: 15913837
[TBL] [Abstract][Full Text] [Related]
18. Characterization of two VQIXXK motifs for tau fibrillization in vitro.
Li W; Lee VM
Biochemistry; 2006 Dec; 45(51):15692-701. PubMed ID: 17176091
[TBL] [Abstract][Full Text] [Related]
19. C-terminal truncation modulates both nucleation and extension phases of tau fibrillization.
Yin H; Kuret J
FEBS Lett; 2006 Jan; 580(1):211-5. PubMed ID: 16364303
[TBL] [Abstract][Full Text] [Related]
20. High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation.
Crowe A; Ballatore C; Hyde E; Trojanowski JQ; Lee VM
Biochem Biophys Res Commun; 2007 Jun; 358(1):1-6. PubMed ID: 17482143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
